Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Technique
1.1.2 Indication
1.1.3 End Use
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.2 Volume price analysis (model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1
1.8.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Technique
2.2.2 Indication
2.2.3 End Use
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Market Lineage Outlook
3.2.1 Parent Market Outlook
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increase in target population and disease prevalence
3.3.1.2 Increasing adoption of AI-based imaging solutions
3.3.1.3 Increase in adoption of MRI techniques
3.3.1.4 Supportive regulations and adequate insurance coverage
3.3.2 Market Restraint Analysis
3.3.2.1 Adverse effects or allergies of contrast dyes (Safety concerns)
3.3.2.2 High cost of MRA procedures
3.4 U.S. Magnetic Resonance Angiography (MRA) Market: Business Environment Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.1.1 Threat of new entrants
3.4.1.2 Bargaining power of suppliers
3.4.1.3 Bargaining power of buyers
3.4.1.4 Competitive rivalry
3.4.1.5 Threat of substitutes
3.4.2 PESTEL Analysis
3.4.2.1 Political & Legal
3.4.2.2 Economic
3.4.2.3 Technological
3.5 Penetration & Growth Prospect Mapping
3.5.1 Penetration Analysis
3.6 Regulatory Scenario & Reimbursement Framework
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & acquisitions and joint ventures
3.7.2 Technology collaborations
Chapter 4 U.S. Magnetic Resonance Angiography (MRA) Market: Technique Analysis
4.1 U.S. Magnetic Resonance Angiography (MRA) Technique Market Share Analysis, 2019 & 2027
4.2 U.S. Magnetic Resonance Angiography (MRA) Technique Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Technique Segment
4.3.1 Contrast Enhanced MRA
4.3.1.1 Contrast enhanced MRA market, 2016 - 2027 (USD Million)
4.3.2 Non-contrast Enhanced MRA
4.3.2.1 Non-contrast enhanced MRA market, 2016 - 2027 (USD Million)
Chapter 5 U.S. Magnetic Resonance Angiography (MRA) Market: Indication Analysis
5.1 U.S. Magnetic Resonance Angiography (MRA) Indication Market Share Analysis, 2019 & 2027
5.2 U.S. Magnetic Resonance Angiography (MRA) Indication Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Indication Segment
5.3.1 Abdomen
5.3.1.1 Abdomen MRA market, 2016 - 2027 (USD Million)
5.3.2 Lower Extremities
5.3.2.1 Lower extremities MRA market, 2016 - 2027 (USD Million)
5.3.3 Others
5.3.3.1 Others market, 2016 - 2027 (USD Million)
Chapter 6 U.S. Magnetic Resonance Angiography (MRA) Market: End Use Analysis
6.1 U.S. Magnetic Resonance Angiography (MRA) End Use Market Share Analysis, 2019 & 2027
6.2 U.S. Magnetic Resonance Angiography (MRA) End Use Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the End Use Segment
6.3.1 Hospitals
6.3.1.1 Hospitals market, 2016 - 2027 (USD Million)
6.3.2 Imaging Centers
6.3.2.1 Imaging centers market, 2016 - 2027 (USD Million)
6.3.3 Ambulatory Surgical Centers & Other Healthcare Settings
6.3.3.1 Ambulatory surgical centers & other healthcare settings market, 2016 - 2027 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.3 Vendor Landscape
7.3.1 Company market position analysis (Geographic presence, product portfolio, employee strength, etc.)
7.3.2 Market Ranking, 2019
7.4 Key Company Profiles: Manufacturers
7.4.1 GE Healthcare
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 Koninklijke Philips N.V.
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 Siemens Healthcare GmbH
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 Hitachi, Ltd.
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 Canon, Inc.
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 Shenzhen Anke Hi-Tech Co., Ltd.
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.7 Time Medical Holding
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
7.4.8 ASG Superconductors spa
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.9 Neusoft Corporation
7.4.9.1 Company overview
7.4.9.2 Product benchmarking
7.4.9.3 Strategic initiatives
7.4.10 Shimadzu Corporation
7.4.10.1 Company overview
7.4.10.2 Product benchmarking
7.4.11 ESAOTE SPA
7.4.11.1 Company overview
7.4.11.2 Financial performance
7.4.11.3 Product benchmarking
7.4.11.4 Strategic initiatives
7.4.12 AllTech Medical Systems
7.4.12.1 Company overview
7.4.12.2 Financial performance
7.4.12.3 Product benchmarking
7.4.12.4 Strategic initiatives
7.5 Key Company Profiles: Service Providers
7.5.1 Envision Radiology
7.5.1.1 Company overview
7.5.1.2 Service benchmarking
7.5.2 CentraCare
7.5.2.1 Company overview
7.5.2.2 Service benchmarking
7.5.3 Radiology Associates of Ocala
7.5.3.1 Company overview
7.5.3.2 Service benchmarking
7.5.4 Hunt Regional Healthcare
7.5.4.1 Company overview
7.5.4.2 Service benchmarking
7.5.5 Montgomery Radiology Associates
7.5.5.1 Company overview
7.5.5.2 Service benchmarking
7.5.6 Dignity Health
7.5.6.1 Company overview
7.5.6.2 Service benchmarking
7.5.6.3 Strategic initiatives
7.5.7 Cedars-Sinai
7.5.7.1 Company overview
7.5.7.2 Service benchmarking
7.5.8 Kalispell Regional Healthcare
7.5.8.1 Company overview
7.5.8.2 Service benchmarking
7.5.9 UVA Health, bnk
7.5.9.1 Company overview
7.5.9.2 Service benchmarking
7.5.10 Fairfax Radiology
7.5.10.1 Company overview
7.5.10.2 Service benchmarking
7.5.10.3 Strategic initiatives
7.5.11 Larchmont Medical Imaging
7.5.11.1 Company overview
7.5.11.2 Service benchmarking
7.5.12 Icahn School of Medicine at Mount Sinai
7.5.12.1 Company overview
7.5.12.2 Service benchmarking
7.5.13 Sansum Clinic
7.5.13.1 Company overview
7.5.13.2 Service benchmarking
7.5.14 Insight Medical
7.5.14.1 Company overview
7.5.14.2 Service benchmarking
7.5.15 ARA Diagnostic Imaging
7.5.15.1 Company overview
7.5.15.2 Service benchmarking
Chapter 8 Recommendations
Chapter 9 KOL Commentary



List of Tables



TABLE 1 List of Secondary Sources